1. BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results. Issue 6 (17th October 2019) Authors: Lalezari, Shadan; Reding, Mark T.; Pabinger, Ingrid; Holme, Pal Andre; Negrier, Claude; Chalasani, Pavani; Shin, Ho‐Jin; Wang, Maria; Tseneklidou‐Stoeter, Despina; Maas Enriquez, Monika Journal: Haemophilia Issue: Volume 25:Issue 6(2019) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study. Issue 3 (5th April 2021) Authors: Reding, Mark T.; Pabinger, Ingrid; Holme, Pal Andre; Poulsen, Lone; Negrier, Claude; Chalasani, Pavani; Maas Enriquez, Monika; Wang, Maria; Meijer, Karina; Mancuso, Maria Elisa; Lalezari, Shadan Journal: Haemophilia Issue: Volume 27:Issue 3(2021) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study. Issue 7 (25th July 2018) Authors: Resseguier, Noémie; Rosso-Delsemme, Natacha; Beltran Anzola, Any; Baumstarck, Karine; Milien, Vanessa; Ardillon, Laurent; Bayart, Sophie; Berger, Claire; Bertrand, Marie-Anne; Biron-Andreani, Christine; Borel-Derlon, Annie; Castet, Sabine; Chamouni, Pierre; Claeyssens Donadel, Ségolène; De Raucou... Journal: BMJ open Issue: Volume 8:Issue 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation. (30th October 2015) Authors: Dargaud, Yesim; Jourdy, Yohann; Le Quellec, Sandra; Hemker, Coenraad H.; Lindhout, Theo; Castoldi, Elisabetta; Negrier, Claude Journal: British journal of haematology Issue: Volume 174:Number 6(2016) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus. Issue 6 (September 2018) Authors: Seuser, Axel; Djambas Khayat, Claudia; Negrier, Claude; Sabbour, Adly; Heijnen, Lily Journal: Blood coagulation and fibrinolysis Issue: Volume 29:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity. Issue 5 (May 2015) Authors: Perot, Eloïse; Enjolras, Nathalie; Le Quellec, Sandra; Indalecio, Alice; Girard, Jonathan; Negrier, Claude; Dargaud, Yesim Journal: Thrombosis research Issue: Volume 135:Issue 5(2015) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity. Issue 5 (May 2015) Authors: Perot, Eloïse; Enjolras, Nathalie; Le Quellec, Sandra; Indalecio, Alice; Girard, Jonathan; Negrier, Claude; Dargaud, Yesim Journal: Thrombosis research Issue: Volume 135:Issue 5(2015) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Factor XI and traveling waves: the key to understanding coagulation in hemophilia?. Issue 2 (April 2013) Authors: Ataullakhanov, Fazoil I; Dashkevich, Natalia M; Negrier, Claude; Panteleev, Mikhail A Journal: Expert review of hematology Issue: Volume 6:Issue 2(2013) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate). Issue 5 (July 2016) Authors: Negrier, Claude; Voisin, Sophie; Baghaei, Fariba; Numerof, Robert; Novack, Aaron; Doralt, Jennifer E.; Romanov, Vadim; Gringeri, Alessandro Journal: Blood coagulation and fibrinolysis Issue: Volume 27:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate). Issue 5 (July 2016) Authors: Negrier, Claude; Voisin, Sophie; Baghaei, Fariba; Numerof, Robert; Novack, Aaron; Doralt, Jennifer E.; Romanov, Vadim; Gringeri, Alessandro Journal: Blood coagulation and fibrinolysis Issue: Volume 27:Issue 5(2016) Page Start: 551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗